Chronic Disease | Drug Descriptions | ATC Codes |
---|---|---|
Alzheimer's | Anticholinesterase agents | N06DA; N06DX |
 | Digitalis glycosides, antiarrhythmics, diuretics, beta-adrenergic | C01AA; C01BA; C01BB; C01BC; C01BD; C01DA; |
Cardiovascular diseases | blockers, alpha blockers, ACE inhibitors, calcium channel | C02AB; C02AC;C02CA; C03AA; C03BA; C03CA; |
 | blockers, antihypertensive vasodilators | C03CX; C03DA; C03EA; C03EB; C07AA; C07AB; |
Chronic hepatitis | Interferons* | L03AB |
Chronic renal disease | Agents for hyperkalaemia and hyperphosphataemia | V03AE; B03XA |
Chronic respiratory illnesses | Inhaled corticosteroids, beta-2-adrenoreceptor agonist, | R03AC; R03AK; R03BA; R03BB; R03BC; R03CC; |
 | xanthines, leucotriene antagonists, cromolyn | R03DA; R03DC |
Cirrhosis | Blood substitutives and plasmatic protein fractions* | B05AA; B02BA |
Crohn's and ulcerative colitis | Intestinal corticosteroid agents | A07EA; A07EC |
 |  | A10AB; A10AC; A10AD; A10AE; A10BA; A10BB; |
Diabetes | Insulins, biguanides, sulphonylureas | A10BD; A10BG; A10BX |
 |  | N03AA; N03AB; N03AD; N03AE; N03AF; N03AG; |
Epilepsy | Anticonvulsivant barbiturates and congeners | N03AX |
 | Sympaticomimetic agents*, parasympaticomimetic |  |
Glaucoma | agents, anhydrase inhibitors*, ophthalmic beta blockers | S01EA; S01EB; S01EC; S01ED; S01EE; S01EX |
HIV/AIDS | Nucleosides and nucleotides*, reverse transcriptase inhibitors | J05AB; J05AD; J05AF |
 |  | A04AA; H01CB; L01AA; L01AB; L01AX; L01BA; |
 |  | L01BB; L01BC; L01DB; L01XB; L01XX; L02AB; |
Malignancies | Antineoplastics, 5HT3 antagonists* | L02AE; L02BA; L02BB; L02BG; L03AA; L03AX; |
 |  | R05DA; R05DB27 |
Migraine | Ergot alkaloids, 5HT1 agonists | N02CA; N02CC; N02CX |
Paget's disease/other | Â | H05AA02; H05AA03; H05BA; M05BA; M05BB; |
osteoporosis chronic | Bisphosphonates*, calcitonin* | G03XC01; M05BX; A12AA; A12AX |
conditions | Â | Â |
Parkinson's | Dopamine, MAO b inhibitors | N04AA; N04AB; N04BA; N04BC; N04BX |
Psoriasis | Oral and topical antipsoriasis agents | D05AX; D05BB |
 |  | N05AA; N05AB; N05AC; N05AD; N05AF; N05AG; |
Psychiatric disorders | Antidepressants, antipsychotics agents | N05AH; N05AL; N05AN; N05AX; N05BA; N05AA; |
 |  | N06AB; N06AX |
 |  | M01AB; M01AC; M01AE; M01AG; M01AH; M01AX; |
Rheumatological conditions | Anti-inflammatory non-steroids*, gold salts, aminoquinolines | M01CB; M01CC; P01BA |
Thyroid disorders | Thyroid replacement, antithyroid agents | H03AA; H03BB; H03BC |
Tuberculosis | Antituberculosis antibiotics*, isoniazid | J04AB; J04AC; J04AK; J04AM |